Cite
Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry.
MLA
Noor, Nudrat, et al. “Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry.” Diabetes Care, vol. 44, no. 8, Aug. 2021, pp. e160–62. EBSCOhost, https://doi.org/10.2337/dc21-0074.
APA
Noor, N., Ebekozien, O., Levin, L., Stone, S., Sparling, D. P., Rapaport, R., & Maahs, D. M. (2021). Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry. Diabetes Care, 44(8), e160–e162. https://doi.org/10.2337/dc21-0074
Chicago
Noor, Nudrat, Osagie Ebekozien, Laura Levin, Sheri Stone, David P. Sparling, Robert Rapaport, and David M. Maahs. 2021. “Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry.” Diabetes Care 44 (8): e160–62. doi:10.2337/dc21-0074.